Blackstone Inc Vbi Vaccines Inc Call Options Transaction History
Blackstone Inc
- $21.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VBIV
# of Institutions
2Shares Held
688KCall Options Held
0Put Options Held
0About VBI Vaccines Inc
- Ticker VBIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 258,256,992
- Market Cap $5.17M
- Description
- VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...